Genscript - Model SARS-CoV-2 Spike S1-RBD IgG & IgM -ELISA Detection Kit
The GenScript SARS-CoV-2 Spike S1-RBD IgG&IgM ELISA Detection Kit is intended for the determination of IgG and IgM antibodies separately against SARS-CoV-2 Spike S1-Receptor Binding Domain (RBD) in human serum or plasma. The kit can be used to evaluate the immune efficacy of mRNA COVID-19 vaccines.
If you need kits to detect total antibodies (including IgA, IgM and IgG) against RBD and N protein or evaluate the immune efficacy of inactivated vaccines, you can learn about SARS-CoV-2 NP&RBD Total Antibody ELISA Kit (GenScript, L00846)
Intra-assay: One known level of control was spiked into sample buffer as a test sample. The sample was tested 10 times on the same plate to evaluate intra-assay precision of the kit. Intra-assay variation of this kit is less than or equal to 10%.
Inter-assay: One known level of control was spiked into sample buffer as a test sample. The sample was tested on 3 plates which were randomly selected from 3 different lots to evaluate inter-assay precision of the kit. Inter-assay variation of this kit is less than or equal to 15%.
- Storage The unopened kit is stable for at least 12 months from the date of manufacture if stored at 2 to 8°C, and the opened kit is stable for up to 1 month from the date of opening at 2 to 8°C.
- Note For Research Use Only. Not for Use in Diagnostic Procedures. The operator should read technical manual carefully before using this product.
